EVH vs HUM
EVH: Evolent Health connects specialty care for complex chronic conditions through evidence-based clinical pathways and provider networks aligned with payers to improve outcomes and reduce costs. HUM: Integrated health insurance and care services operator with 15 million medical members, delivering Medicare Advantage, Medicaid, and primary care through its dual Insurance and CenterWell platforms.
Side-by-side fundamentals
| Metric | EVH | HUM | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $5.57 | $397.60 | |
| Market cap as of 2026-07-23 | $630M | $48.0B | |
| P/E as of 2026-07-23 | n/a | 42.51 | |
| PEG as of 2026-07-23 | -0.00 | 2.29 | EVH lower |
| Net margin as of 2026-07-23 | -26.3% | +0.8% | HUM higher |
| Gross margin as of 2026-07-23 | +20.2% | n/a | |
| Operating margin as of 2026-07-23 | -23.2% | +1.7% | HUM higher |
| ROE as of 2026-07-23 | -71.5% | +6.2% | HUM higher |
| ROA as of 2026-07-23 | -22.9% | +2.2% | HUM higher |
| Debt / equity as of 2026-07-23 | 2.46 | 0.75 | HUM lower |
| Revenue growth (YoY) as of 2026-07-23 | -21.3% | +14.1% | HUM higher |
| Revenue CAGR (3y) SEC XBRL | +11.5% | +11.8% | HUM higher |
| Dividend yield as of 2026-07-23 | n/a | +0.9% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.71 | 0.75 | |
| 1-year return as of 2026-07-22 close | -40.1% | +72.0% | HUM higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.